Treatment

Dabigatran Etexilate GLN 150 mg hard capsules clinical trials

1 indexed studies · 0 currently recruiting

AuthorisedTherapeutic use (Phase IV)
Short-Term Anticoagulation versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure. The ANDES study.
This study, called ANDES, looks at different blood-thinning medicines given for a short time after a procedure called Left Atrial Appendage Closure (LAAC). It aims to find the best way to prevent blood clots forming on the device used in the heart, especially for people with an irregular heartbeat.
For: Atrial Fibrillation Device thrombosis post-Left Atrial Appendage Closure
Spain